Randomized controlled trials provide essential evidence for the evaluation of new and existing medical treatments. Unfortunately, the statistical analysis is often complicated by the occurrence of protocol deviations, which mean we cannot always measure the intended outcomes for individuals who deviate, resulting in a missing-data problem. In such settings, however one approaches the analysis, an untestable assumption about the distribution of the unobserved data must be made. To understand how far the results depend on these assumptions, the primary analysis should be supplemented by a range of sensitivity analyses, which explore how the conclusions vary over a range of different credible assumptions for the missing data. In this article, ...
The statistical analysis of longitudinal randomised controlled trials is frequently complicated by t...
Missing data are a common issue in cost-effectiveness analysis (CEA) alongside randomised trials and...
The importance of preventing and treating incomplete data in effectiveness studies is nowadays empha...
Randomized controlled trials provide essential evidence for the evaluation of new and existing medic...
Missing data due to loss to follow-up or intercurrent events are unintended, but unfortunately inevi...
Missing data due to loss to follow-up or intercurrent events are unintended, but unfortunately inevi...
Analysis of longitudinal randomised controlled trials is frequently complicated because patients dev...
<p>Reference-based imputation (RBI) methods have been proposed as sensitivity analyses for longitudi...
<div><p>Reference-based imputation (RBI) methods have been proposed as sensitivity analyses for long...
Protocol deviations, for example, due to early withdrawal and noncompliance, are unavoidable in clin...
Protocol deviations, for example, due to early withdrawal and noncompliance, are unavoidable in clin...
Analysis of longitudinal randomized clinical trials is frequently complicated because patients devia...
The importance of preventing and treating incomplete data in effectiveness studies is nowadays empha...
In clinical trials, missing data commonly arise through nonadherence to the randomized treatment or ...
The objective of this research was to demonstrate a framework for drawing inference from sensitivity...
The statistical analysis of longitudinal randomised controlled trials is frequently complicated by t...
Missing data are a common issue in cost-effectiveness analysis (CEA) alongside randomised trials and...
The importance of preventing and treating incomplete data in effectiveness studies is nowadays empha...
Randomized controlled trials provide essential evidence for the evaluation of new and existing medic...
Missing data due to loss to follow-up or intercurrent events are unintended, but unfortunately inevi...
Missing data due to loss to follow-up or intercurrent events are unintended, but unfortunately inevi...
Analysis of longitudinal randomised controlled trials is frequently complicated because patients dev...
<p>Reference-based imputation (RBI) methods have been proposed as sensitivity analyses for longitudi...
<div><p>Reference-based imputation (RBI) methods have been proposed as sensitivity analyses for long...
Protocol deviations, for example, due to early withdrawal and noncompliance, are unavoidable in clin...
Protocol deviations, for example, due to early withdrawal and noncompliance, are unavoidable in clin...
Analysis of longitudinal randomized clinical trials is frequently complicated because patients devia...
The importance of preventing and treating incomplete data in effectiveness studies is nowadays empha...
In clinical trials, missing data commonly arise through nonadherence to the randomized treatment or ...
The objective of this research was to demonstrate a framework for drawing inference from sensitivity...
The statistical analysis of longitudinal randomised controlled trials is frequently complicated by t...
Missing data are a common issue in cost-effectiveness analysis (CEA) alongside randomised trials and...
The importance of preventing and treating incomplete data in effectiveness studies is nowadays empha...